Nitches Inc. (OTC:NICH) Announces Discussions for Strategic Joint Venture with Major cGMP Manufacturing Facility

Rhea-AI Summary

Nitches (OTC:NICH) reported that it is in active discussions for a strategic joint venture with a major U.S.-based cGMP-certified manufacturing facility. The contemplated structure would position Nitches’ NutraVeri platform as a dedicated marketing and customer-acquisition arm for brands needing formulation, manufacturing, fulfillment, and commercialization services.

If completed, the joint venture would link NutraVeri’s network of supplement brands, readiness scoring, and commercialization tools with the manufacturing partner’s cGMP expertise and production capacity to create an end-to-end solution from concept validation through long-term growth. According to Nitches, NutraVeri is expected to act as a primary lead-generation platform, helping identify qualified brands and directing them into an integrated manufacturing ecosystem. The company cautioned that there is no assurance the discussions will result in definitive agreements or a completed transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MIAMI, FL / ACCESS Newswire / August 5, 2026 / Nitches Inc. (OTCID:NICH) today announced that it is in active discussions regarding a strategic joint venture with a major U.S.-based cGMP-certified manufacturing facility. The proposed collaboration is intended to establish Nitches and its NutraVeri platform as a dedicated marketing and customer acquisition arm, creating a streamlined pathway for brands seeking formulation, manufacturing, fulfillment, and commercialization services.

If completed, the joint venture would combine NutraVeri's growing network of supplement brands, readiness scoring, and commercialization tools with the manufacturing expertise and production capabilities of an established cGMP facility. The goal is to provide emerging and established brands with a seamless, end-to-end solution-from concept validation and manufacturing through fulfillment and long-term growth.

"This opportunity reflects our vision of building more than a software platform," said John Morgan, Chief Executive Officer of Nitches Inc. "Our objective is to become the front door for brands entering the nutritional supplement market, connecting qualified companies with world-class manufacturing partners while simplifying what has traditionally been a fragmented process."

Under the proposed structure, NutraVeri would serve as a primary marketing and lead-generation platform, helping identify qualified brands and directing them into an integrated manufacturing ecosystem. The collaboration is expected to enhance customer acquisition, accelerate time-to-market, and create additional revenue opportunities for both organizations.

Nitches expects to provide additional information if and when definitive agreements are executed. There can be no assurance that the discussions will result in a completed transaction.

About NutraVeri
NutraVeri is Nitches Inc.'s supplement readiness and commercialization platform designed to help brands evaluate their preparedness before entering manufacturing. Through deterministic scoring and actionable insights, NutraVeri seeks to improve the likelihood of successful product launches while connecting brands with trusted industry partners.

About Nitches Inc.
Nitches Inc. (OTCID:NICH) is developing technology-driven platforms that simplify product commercialization and help businesses navigate the path from concept to market. Through NutraVeri, the Company is building an ecosystem that connects brands with the tools, expertise, and strategic partnerships needed for long-term success.

Investor Relations
John Morgan
Nitches Inc.
Email: info@nitchescorp.com

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding proposed joint ventures, strategic partnerships, future business opportunities, anticipated benefits, and the Company's growth strategy. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that may affect actual results include, among others, the inability to execute definitive agreements, changes in market conditions, regulatory developments, and other risks detailed in the Company's filings with the Securities and Exchange Commission. Nitches Inc. undertakes no obligation to update these forward-looking statements except as required by law.

SOURCE: Nitches, Inc.

View the original press release on ACCESS Newswire

FAQ

What joint venture discussions did Nitches (OTC:NICH) announce on August 5, 2026?

Nitches announced active discussions for a strategic joint venture with a major U.S.-based cGMP-certified manufacturing facility. According to Nitches, the proposed collaboration would align its NutraVeri platform with the facility’s production capabilities to support supplement brands from concept through commercialization.

How would NutraVeri be used in the proposed Nitches (NICH) cGMP joint venture?

NutraVeri would act as a primary marketing and lead-generation platform, directing qualified brands into an integrated manufacturing ecosystem. According to Nitches, it would combine readiness scoring and commercialization tools to guide supplement brands toward formulation, manufacturing, fulfillment, and long-term growth.

Is the Nitches (OTC:NICH) NutraVeri joint venture with a cGMP facility finalized?

No, the joint venture is not finalized and remains under active discussion. According to Nitches, definitive agreements have not been executed, and there can be no assurance the talks will result in a completed transaction or specific commercial terms.

What benefits does Nitches expect from the potential NutraVeri cGMP joint venture for NICH shareholders?

The collaboration is expected to enhance customer acquisition and create additional revenue opportunities for both organizations. According to Nitches, integrating NutraVeri with a cGMP manufacturing partner could accelerate time-to-market and provide brands with a seamless, end-to-end commercialization pathway.

What role would the cGMP-certified facility play in the proposed Nitches (NICH) joint venture?

The facility would provide manufacturing expertise and production capabilities for supplement brands entering through NutraVeri. According to Nitches, combining cGMP production with NutraVeri’s marketing and readiness tools aims to support formulation, manufacturing, fulfillment, and ongoing brand growth.

What is the NutraVeri platform mentioned in Nitches’ August 2026 joint venture update?

NutraVeri is a supplement readiness and commercialization platform developed by Nitches. According to Nitches, it uses deterministic scoring and actionable insights to assess a brand’s preparedness for manufacturing while connecting companies with trusted industry partners and potential manufacturing ecosystems.